Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct fe
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine
Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping | Cancer Discovery
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients - ScienceDirect
Locations of MET exon 14 genomic alterations found in sarcomatoid... | Download Scientific Diagram
MET exon 14 mutation: another actionable genomic variation in patients with advanced NSCLC - Di Maio - Translational Cancer Research
Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping Sai-Hong Ignatius Ou, MD, PhD, - ppt download
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer
Co-occurring genetic alterations in the RAS pathway promote resistance to MET inhibitor treatment in non-small cell lung cancer with a MET exon 14 skipping mutation | bioRxiv
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration | Nature Medicine
MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life | Clinical Cancer Research
Impaired c-Met Receptor Degradation Mediated by MET Exon 14 Mutations in Non-Small-Cell Lung Cancer. | Semantic Scholar
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro - Journal of Thoracic Oncology
Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers - Lung Cancer
MET Inhibition in Non-Small Cell Lung Cancer - European Medical Journal
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
Identification of tumor-specific, intronic mutations in Met leading to... | Download Scientific Diagram
The genomic position of METex14 alterations. Genome coordinates are... | Download Scientific Diagram
cMET Exon 14 Skipping: From the Structure to the Clinic - ScienceDirect
Figure 2 from MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. | Semantic Scholar
Expanding treatment options in NSCLC patients with rare mutations: ALK, ROS1, MET, BRAF - memoinOncology
Diagnosis and Discussion -- Case 1068
Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation - Lung Cancer
The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable - ScienceDirect
